Veterinary Infectious Disease Diagnostics Market Size & Share, By Technology (Molecular Diagnostics, Immunodiagnostics), Animal Type (Food Producing Animals and Companion Animals), End User (Veterinary Laboratories and Clinics, Reference Laboratories, Research Institutes and Universities and Point of Care / In House Testing) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Market Outlook:

Veterinary Infectious Disease Diagnostics Market size is predicted to grow from USD 7.74 billion in 2024 to USD 18.16 billion by 2034, reflecting a CAGR of over 8.9% from 2025 through 2034. The industry revenue is forecasted to reach USD 8.29 billion in 2025.

• Base Year Value (2024): USD 7.74 billion
• CAGR (2025-2034): 8.9%
• Forecast Year Value (2034): USD 18.16 billion
• Historical Data Period: 2019-2024
• Largest Region: North America
• Forecast Period: 2025-2034

Market Dynamics:

Growth Drivers & Opportunities:

The Veterinary Infectious Disease Diagnostics Market is experiencing significant growth, driven primarily by the increasing prevalence of infectious diseases in animals. As pet ownership continues to rise globally, there is a heightened emphasis on maintaining animal health, leading to greater demand for accurate and timely diagnostics. This trend is further supported by advancements in technology, including the development of innovative diagnostic tools such as PCR tests, serological assays, and rapid test kits that enhance the speed and accuracy of disease detection.

Another key growth driver is the surge in research and development activities aimed at understanding infectious diseases that affect both domestic and livestock animals. This research not only contributes to the discovery of new diagnostic methods but also helps in the formulation of effective treatment plans and vaccines. Furthermore, collaborations between veterinary clinics, research institutions, and pharmaceutical companies are fostering innovations that cater to the evolving needs of animal healthcare, thus creating lucrative opportunities within the market.

The rising awareness about zoonotic diseases, which can transfer from animals to humans, is also propelling the demand for veterinary diagnostics. Governments and health organizations are investing in awareness campaigns and preventive measures against zoonotic diseases, thereby bolstering the need for efficient diagnostic tools. The growing trend of pet insurance is another opportunity, as insured pet owners are more likely to seek diagnostic services to ensure the health and well-being of their animals.

Report Scope

Report Coverage	Details
Segments Covered	Technology, Animal Type, End User
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	IDEXX Laboratories, Zoetis, Merck Animal Health, Thermo Fisher Scientific, Agrolab, BioMérieux, Roche Diagnostics, QIAGEN, Avacta, Biomerica

Industry Restraints:

Despite the promising growth landscape, the Veterinary Infectious Disease Diagnostics Market faces several restraints that could hinder its expansion. High costs associated with advanced diagnostic technologies can be a significant barrier, particularly for small veterinary practices and clinics that may lack the resources to invest in cutting-edge diagnostic equipment. This often leads to disparities in the availability of diagnostic services across different regions, limiting access for some pet owners and livestock producers.

Regulatory challenges also pose a constraint to market growth. The approval processes for new diagnostic products can be lengthy and complex, which may delay the introduction of innovative solutions into the market. Additionally, compliance with stringent regulations regarding animal testing and diagnostic procedures can add to the operational burdens faced by companies in this industry.

Moreover, there is a lack of skilled professionals proficient in the latest diagnostic techniques, which can affect the quality of diagnostics offered. The veterinary health sector often grapples with workforce shortages, particularly in rural areas, where veterinary services are crucial. This skill gap may hinder the effective implementation of new diagnostic technologies and limit the overall growth potential of the market.

Regional Forecast:

North America

The North American veterinary infectious disease diagnostics market is anticipated to remain robust, primarily driven by the United States and Canada. The U.S. is expected to dominate the market due to its advanced healthcare infrastructure, significant investment in veterinary research, and a high prevalence of pet ownership. This has led to a rising demand for diagnostic testing, particularly in the context of zoonotic diseases. Canada is also showing growth potential, with increased awareness regarding animal health and welfare, along with growing governmental support for veterinary research initiatives.

Asia Pacific

In the Asia Pacific region, countries such as China, Japan, and South Korea are gaining prominence within the veterinary infectious disease diagnostics market. China is projected to show the largest market size, driven by its vast livestock population and increasing investment in veterinary healthcare and diagnostics. There is a growing focus on disease prevention, which further propels the market. Japan and South Korea are also expected to exhibit notable growth, thanks to their advanced technology adoption in veterinary diagnostics, along with increased governmental regulations aimed at improving animal health standards.

Europe

Within Europe, the UK, Germany, and France are key players in the veterinary infectious disease diagnostics market. The UK is likely to showcase substantial market growth due to a strong emphasis on pet care and increased consumer spending on veterinary services. Germany has a well-established veterinary care system and is anticipated to maintain a significant market size due to its focus on animal health and welfare. France, with its rising demand for advanced diagnostic technologies and increasing awareness of infectious diseases in pets and livestock, contributes to the growing landscape of veterinary diagnostics.

Segmentation Analysis:

In terms of segmentation, the global Veterinary Infectious Disease Diagnostics market is analyzed on the basis of Technology, Animal Type, End User.

Technology

The Veterinary Infectious Disease Diagnostics Market is significantly shaped by advancements in diagnostic technologies. Key segments in this category include molecular diagnostics, immunodiagnostics, and traditional diagnostic methods. Molecular diagnostics, particularly PCR and next-generation sequencing, are expected to exhibit the largest market size due to their high accuracy and efficiency in detecting pathogens at a genetic level. Immunodiagnostics, which leverage the body’s immune response in detecting infections, are also anticipated to grow rapidly, driven by the development of rapid tests and point-of-care diagnostics. Traditional methods, while still relevant, are likely to experience slower growth as they face competition from more innovative technologies. Overall, the technological advancements in diagnostics are transforming how veterinary infectious diseases are detected, leading to improved animal health outcomes.

Animal Type

In the animal type segment, the Veterinary Infectious Disease Diagnostics Market is divided into companion animals and livestock. Companion animals, particularly dogs and cats, are expected to hold a substantial share of the market, with an increasing focus on preventive healthcare and the rising incidence of zoonotic diseases contributing to this trend. The livestock segment, which includes cattle, poultry, and pigs, is also poised for significant growth driven by the necessity for disease surveillance and management in food production. As concerns over food safety and veterinary public health continue to rise, diagnostics for livestock will see heightened demand, particularly in regions with dense farming practices. The balance of attention between companion animals and livestock will continually shift based on emerging disease threats and changing consumer preferences in veterinary care.

End User

The end-user segment of the Veterinary Infectious Disease Diagnostics Market encompasses veterinary clinics, diagnostic laboratories, and research institutions. Veterinary clinics are anticipated to experience the largest market size, owing to an increase in pet ownership and the demand for timely diagnostic services. These clinics are becoming integral in early disease detection, thereby enhancing the quality of care for companion animals. Diagnostic laboratories are also expected to exhibit substantial growth, driven by their role in high-throughput testing and specialized disease diagnostics, necessitated by complex infections. Research institutions, while a smaller segment, are crucial for driving innovation through ongoing clinical studies and advancements in veterinary diagnostics. Each of these end users plays a vital role in shaping the market landscape, reflecting the urgency for effective infectious disease management in animals.

Competitive Landscape:

The competitive landscape in the Veterinary Infectious Disease Diagnostics Market is characterized by a mix of established players and emerging companies specializing in diagnostic testing and veterinary health solutions. The market is driven by the increasing prevalence of zoonotic diseases, a rising demand for rapid testing solutions, and advancements in diagnostic technologies such as PCR, ELISA, and next-generation sequencing. Companies are focusing on innovative product development, strategic partnerships, and mergers and acquisitions to enhance their market presence and expand their product portfolios. The market exhibits a high degree of competition, with players striving to improve the accuracy, speed, and cost-effectiveness of diagnostic tests to meet the growing needs of veterinarians and pet owners.

Top Market Players

IDEXX Laboratories

Zoetis

Neogen Corporation

Virbac

Thermo Fisher Scientific

Heska Corporation

Merial

Scil Animal Care Company

BioMérieux

Affymetrix